Evidence map›Paper›PMID 40761784›Full record

ArticleFrontiers in immunology2025

Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid.

Na Zhang, Ming Wang, Lili Hou, Yanyu Zhang, Yan Zhao, Luyang Du, Xiaoqing Li, Xia Liu, Hongwei Zhou, Jiaxuan Hao and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Na Zhang *Department of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ming Wang *Global Academic Department, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China.
Lili Hou *Department of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yanyu ZhangDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yan ZhaoDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Luyang DuGlobal Academic Department, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China.
Xiaoqing LiDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xia LiuDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Hongwei ZhouDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiaxuan HaoDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Jing TianDermatology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Qiuping YuGlobal Academic Department, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China.
Lixia LiGlobal Academic Department, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China.
Fangming ChengReagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China.
Hai-Zhou ZhouDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1576635.].

Indexed as

BP180BP230bullous pemphigoidchemiluminescent immunoassaydesmogleinpemphigus

Identifiers

PMID40761784
PMCPMC12319416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.